Pharmaceuticals News and Research

RSS

SynTheAll Pharmaceutical wins 2015 CMO Leadership Award

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, announced today that SynTheAll Pharmaceutical Co., Ltd., WuXi's small-molecule manufacturing subsidiary, has won a 2015 CMO Leadership Award, which is presented by Life Science Leader magazine based on research conducted by Nice Insight.

30 Jan 2015

Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million

Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and custom manufacturing solutions services to customers located in 85 countries, today announced financial results for the third quarter of fiscal year (FY) 2015, ended December 31, 2014.

30 Jan 2015

ANI Pharmaceuticals launches Etodolac 300mg oral capsules

ANI Pharmaceuticals, Inc. today announced the launch of Etodolac 300mg oral capsules, indicated for use in the management of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and acute pain.

30 Jan 2015

Nuvo Research announces topline results from WF10 Phase 2 allergic rhinitis clinical trial

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced the results of its 16-week, double-blind, placebo-controlled, Phase 2 clinical trial conducted in Germany to compare the safety and efficacy of WF10 and its main constituents (sodium chlorite and sodium chlorate) with saline in patients with refractory allergic rhinitis and to compare the safety and efficacy of WF10 and its main constituents.

30 Jan 2015

Synthetic compound shows antibiotic action against MRSA

Microbiologists and chemists at the University of South Florida have developed and patented a synthetic compound that has shown antibiotic action against methicillin resistant Staphylococcus aureus, also known as MRSA, which can cause many serious infections and deaths.

30 Jan 2015

Researchers move one step closer to treating diabetes with human probiotic pill

Science may be one step closer to treating diabetes with a human probiotic pill, according to new Cornell University research.

30 Jan 2015

Research reveals key protein structure, paves way for better anti-anxiety drugs

When new medicines are invented, the drug may hit the intended target and nullify the symptoms, but nailing a bull's eye - one that produces zero side effects - can be quite elusive.

30 Jan 2015

Immunotherapy expert discusses the concept of precision immunology and personalized medicine

With President Obama's recent State of the Union speech addressing the launch of a national precision medicine initiative to further tackle cancer and other diseases, a leading immunotherapy expert from Rutgers Cancer Institute of New Jersey weighs in on where we stand with precision immunology and personalized medicine and what needs to be accomplished.

30 Jan 2015

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.

30 Jan 2015

EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

EKF Molecular Diagnostics has agreed a collaboration with specialist medtech company ANGLE plc, to investigate the combination of ANGLE's Parsortix circulating tumour cell (CTC) harvesting platform with EKF Molecular's PointMan™ DNA enrichment technology as a liquid biopsy. If successful, the resulting simple blood test could enable the investigation of unexpected ultra-low level mutations in a patient's cancer for personalised cancer care.

29 Jan 2015

Day-to-day chemical exposures linked to earlier menopause

Women whose bodies have high levels of chemicals found in plastics, personal-care products, common household items and the environment experience menopause two to four years earlier than women with lower levels of these chemicals, according to a new study at Washington University School of Medicine in St. Louis.

29 Jan 2015

Researchers receive DoD grant to develop new therapy against nerve agent exposure

University of Nebraska Medical Center researchers have received a $1.9 million grant from the Defense Threat Reduction Agency of the U.S. Department of Defense to develop a new therapy to protect military members from nerve agent exposure.

29 Jan 2015

ADDF awards grant to support initiation of AGB101 Phase 3 trial for aMCI treatment

The Alzheimer's Drug Discovery Foundation announced today a $900,000 grant to AgeneBio, a pharmaceutical company developing innovative therapies for neurologic and psychiatric diseases. The grant will support the initiation of an FDA-registered Phase 3 clinical trial of AGB101, a new therapeutic treatment for amnestic mild cognitive impairment (aMCI).

28 Jan 2015

Paragon Bioservices receives CMO Leadership Awards for 2015

Paragon Bioservices, Inc., a leader in the manufacturing of biopharmaceuticals, has announced today that it has received the CMO Leadership Awards for 2015. Paragon is a leading contract manufacturing organization (CRO-CMO) whose customer base includes global pharmaceutical companies, biotechnology companies, NGOs and government agencies—including the Department of Defense, the National Cancer Institute and the National Institutes of Health (NIH).

28 Jan 2015

Alzheimer's Association announces new research grants to study potential drug therapies

Many academic researchers and pharmaceutical companies have identified new Alzheimer's drug therapy candidates, but lack the funding to move them into human testing. At the same time, few funding sources support early-phase clinical drug trials. As a result, too many promising studies stall out early in the discovery process.

28 Jan 2015

Study finds no evidence that testosterone replacement therapy increases cardiovascular risk

Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, according to a review published in this month's Mayo Clinic Proceedings. The therapy has come under widespread scrutiny in recent months, including by a federal Food and Drug Administration panel convened last fall.

28 Jan 2015

Yale researcher receives 2015 Frontiers of Knowledge Award in Biomedicine

A Spanish foundation has awarded a major scientific prize to Yale researcher Joseph Schlessinger and two colleagues in recognition of their work leading to the first personalized treatments for cancer. The 2015 Frontiers of Knowledge Award in Biomedicine from the Madrid-based BBVA Foundation includes a €400,000 cash prize.

27 Jan 2015

Biolin Scientific acquires the key patent protecting multi-hole, high-throughput ion channel screening

Biolin Scientific today announces the acquisition of a key patent related to performing multi-hole, high-throughput ion channel screening.

27 Jan 2015

Kaleo, CHMI partner to reduce prescription drug-related deaths

Kaleo, a privately-held pharmaceutical company, today announced a national strategic partnership with the Clinton Health Matters Initiative, an initiative of the Clinton Foundation, that will help support its goal of cutting prescription drug-related deaths in half, saving approximately 10,000 lives over five years.

27 Jan 2015

genae announces acquisition of e-novex

genae, a global Contract Research Organization and services provider for the medical industries, announced today the acquisition of e-novex, a leading provider of electronic data tools that change medical research.

27 Jan 2015

Pharmaceuticals News and Research

SynTheAll Pharmaceutical wins 2015 CMO Leadership Award

Neuland Labs' revenues for third quarter of FY 2015 decrease 17% to $17.14 million

ANI Pharmaceuticals launches Etodolac 300mg oral capsules

Nuvo Research announces topline results from WF10 Phase 2 allergic rhinitis clinical trial

Synthetic compound shows antibiotic action against MRSA

Researchers move one step closer to treating diabetes with human probiotic pill

Research reveals key protein structure, paves way for better anti-anxiety drugs

Immunotherapy expert discusses the concept of precision immunology and personalized medicine

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

Day-to-day chemical exposures linked to earlier menopause

Researchers receive DoD grant to develop new therapy against nerve agent exposure

ADDF awards grant to support initiation of AGB101 Phase 3 trial for aMCI treatment

Paragon Bioservices receives CMO Leadership Awards for 2015

Alzheimer's Association announces new research grants to study potential drug therapies

Study finds no evidence that testosterone replacement therapy increases cardiovascular risk

Yale researcher receives 2015 Frontiers of Knowledge Award in Biomedicine

Biolin Scientific acquires the key patent protecting multi-hole, high-throughput ion channel screening

Kaleo, CHMI partner to reduce prescription drug-related deaths

genae announces acquisition of e-novex

Event guide: World ADC Asia eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence